Venenum Biodesign, LLC
Records under this name other than the patents Venenum Biodesign, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Venenum Biodesign, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,306,098 | Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors Lapsed on the fee record Ended Apr 19, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2026 | From the USPTO record |
| US 11,236,055 | Non-systemic TGR5 agonists Lapsed on the fee record Ended Feb 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2026 | From the USPTO record |
| US 10,669,242 | Clostridium difficile toxin inhibitors Lapsed on the fee record Ended Jun 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2024 | From the USPTO record |
| US 10,654,834 | Non-systemic TGR5 agonists Lapsed on the fee record Ended May 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 19, 2024 | From the USPTO record |